MedPath logo

HERBESSER TABLET 30 mg

Prescription Only
Drug type: Therapeutic
ATC code: C08DB01
Dosage form: TABLET
Route of administration: ORAL
Active ingredient: DILTIAZEM HCl; DILTIAZEM HCl

INDICATIONS

  • Angina pectoris, variant angina pectoris
  • Essential hypertension (mild to moderate)

CONTRAINDICATIONS (HERBESSER and HERBESSER 60 are contraindicated in the following patients.)

  1. Patients with severe congestive heart failure. [The symptoms of heart failure may be exacerbated.]
  2. Patients with 2nd- or 3rd-degree atrioventricular block or sick sinus syndrome (continuous sinus bradycardia (less than 50 beats/minute), sinus arrest, sinoatrial block, etc.) [Excessive inhibition of sinus rhythm and cardiac conduction may occur.]
  3. Patients with a history of hypersensitivity to any of the ingredients in the drug.
  4. Pregnant women or women who may possibly be pregnant, etc. [See PRECAUTIONS – Use during Pregnancy, Delivery or Lactation – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.]
  5. Patients receiving ivabradine hydrochloride. [See “Drug Interactions” section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.]

DOSAGE AND ADMINISTRATION

  • Angina pectoris, variant angina pectoris

    The usual adult dosage for oral use is 30 mg of diltiazem hydrochloride three times a day (90 mg/day). The dosage may be increased to 60 mg three times a day (180 mg/day), if necessary.

  • Essential hypertension (mild to moderate)

    The usual adult dosage for oral use is 30 to 60 mg of diltiazem hydrochloride three times a day (90 – 180 mg/day). The dosage may be adjusted depending on the patient’s age and symptoms.

Registrant
MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
Approval Date
1988-04-28
Approval Number
SIN00428P
Manufacturer
PT Mitsubishi Tanabe Pharma Indonesia
Licence Holder
MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.